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[The following article by Barbara J. Fraser is reprinted with the permission of Noticias Aliadas in
Lima, Peru. It first appeared in the May 3, 1999, edition of the weekly publication Latinamerica
Press.]
Wearing traditional ponchos, feathers and beads, and flanked by their wives and several
environmental lawyers in business suits, two indigenous shamans filed a petition on March 30 in
Washington, DC, to revoke a patent issued 13 years ago on their most sacred plant. Querubin Queta
Alvarado, a Cofan shaman from Ecuador, and Antonio Jacanamijoy Rosero, an Inga elder from
Colombia, presented the papers to the US Patent and Trade Office on behalf of indigenous groups
throughout the Amazon Basin.
At issue is Banisteriopsis caapi, a vine known locally as yage, which, when combined with other
ingredients, produces ayahuasca, a potent hallucinogen used by many Amazonian indigenous
groups in religious rituals. In 1986, Loren Miller, a California resident, was granted a patent for the
plant, which he called Da Vine.
Indigenous groups consider patenting their sacred plant a violation of their culture and religion and
compare it to "patenting the Christian cross." "Our concern isn't so much a commercial one whether
products derived from this plant can be marketed. It's also a cultural and spiritual question," said
Antonio Jacanamijoy, son of one of the shamans and general coordinator of the Coordinadora de las
Organizaciones Indigenas de la Cuenca Amazonica (COICA), based in Quito, Ecuador.
Lawyers, meanwhile, argue that the plant should not be patentable under US law. Indigenous
leaders hope the case, which spans two continents and a maze of national and international
legislation, will set a precedent for the handling of future patent requests. COICA, the legal
advisers, and the US-based Coalition for Amazonian Peoples and their Environment, which joined
forces to challenge the patent, say it is more than a case of one plant. In a letter accompanying
the petition, David R. Downes, senior attorney of the Washington-based Center for International
Environmental Law (CIEL), urged that traditional knowledge be taken into account in evaluating
patent applications.
A person applying for a patent must prove the product is novel, so the process depends heavily
on published information. Traditional knowledge of indigenous people, however, is passed orally
from generation to generation and is largely unknown to the rest of the world. In addition, Downes
said, patenting a plant that is "an important element of a widely held religious system" raises ethical
questions.
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Patents are meant to safeguard an inventor's investment and right to benefit from marketing an
invention. A patent only protects the inventor's right to market the product in the country where the
patent is granted. Plant patents were designed to protect flower and fruit growers who developed
new varieties. The lawyers claim that existing, already identified plant varieties are not eligible for
patents, and say the yage case underscores a flaw in the patent system. Experts say Banisteriopsis
caapi grows throughout the Amazon and that the plant described in the patent matches descriptions
of samples collected earlier by researchers. There is no evidence, they say, that the patent holder
improved or modified the plant, which he grew from a cutting taken to the US from Ecuador.
As a result, Downes said, the patent is inconsistent with the law's intent. "It claims the plant is novel
because the patent owner identified its medicinal characteristics, [but] the indigenous people in the
Amazon have known for many generations the medicinal qualities of this plant," Downes said. In
part, the case highlights problems that arise when two cultures collide. Indigenous societies tend
to value collective or communal rights, while patent law, like most national legislation, emphasizes
individual rights.
Complicating the matter is that indigenous cultures are based on oral tradition, while national legal
systems depend on written laws. For centuries the Amazon Basin, with its many ethnic groups
and rich biological diversity, has attracted the attention of prospectors from rubber tappers to gold
miners to oil drillers. Indigenous leaders consider bioprospecting the collection of plant and animal
samples from which marketable products, particularly pharmaceuticals, could be derived merely
the newest wave. Without political clout or title to the territories they have traditionally inhabited,
the small indigenous groups scattered throughout the Amazon tend to be swept aside by their
countries' interest in export earnings from exploitation of natural resources.
"Unfortunately, indigenous peoples do not control the natural resources that exist in their territories
because these resources have been declared patrimony of the state," said Rodrigo de la Cruz of the
COICA legal team. "Biodiversity and genetic resources are also considered sovereign resources of
the state." "The communities really have no legal control over these resources and are not allowed
to take part when access contracts are signed," he said. "Even traditional knowledge, which belongs
collectively to an indigenous people, has been considered a sovereign resource belonging to a state."
Indigenous leaders say they do not want to withhold knowledge about medicinal plants, for
example that could benefit the world. "It isn't that indigenous peoples are against contributing
to new research," de la Cruz said, "but traditional knowledge has been improperly usurped, and
indigenous people have not benefitted from the activities generated by the research." No laws
specifically govern bioprospecting. Several international agreements call for indigenous peoples to
benefit from the use of resources found in their territories, but do not specify how this should be
done. While some research organizations are exploring benefit- sharing arrangements, Jacanamijoy
is skeptical.
"So far, we've had no favorable experience" with universities or pharmaceutical companies, he says.
"The only solution is to organize ourselves and propose our own law that will allow us to defend
ourselves." Above all, he says, indigenous communities must be educated about their rights. "A
researcher befriends one of our taitas (elders), only it isn't the same kind of friendship that the taita
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offers, but a friendship seen in economic terms," Jacanamijoy says. "The researcher gets all the
information, and this constitutes the flight of our traditional knowledge. It's difficult to keep this
from happening. We'd have to do consciousness- raising in every community."
In his book Protecting What's Ours: Indigenous Peoples and Biodiversity, David Rothschild of
the Coalition for Amazonian Peoples and their Environment points out two major weaknesses of
international agreements. First, long rounds of negotiation tend to produce watered-down language,
urging only that "appropriate measures" be taken "whenever possible." In addition, while many
countries may approve the language of an international treaty, the document is only binding on
those whose governments actually ratify the agreement. Jacanamijoy adds that national legislation
may render international agreements ineffective.
The Convention on Biological Diversity, he says, "is applied according to national legislation, and
national laws often run counter to the proposals of indigenous peoples." Indigenous organizations
say that several international agreements, particularly the International Labor Organization
Convention 169 and the UN Convention on Biological Diversity, are steps in the right direction.
Others, such as the 1994 Uruguay Round of the General Agreement on Tariffs and Trade (GATT),
which addressed trade- related intellectual-property rights or TRIPs, do not take indigenous peoples
into account.
Article 15 of Convention 169 protects "the rights of the peoples concerned to the natural resources
pertaining to their lands (including) the right of indigenous peoples to participate in the use,
management, and conservation of these resources." When the government retains ownership
of resources, the convention calls for consulting the indigenous groups, adding, "The peoples
concerned shall wherever possible participate in the benefits of such activities, and shall receive fair
compensation for any damages which they may sustain as a result of such activities."
The UN Convention on Biological Diversity, approved at the 1992 Earth Summit in Rio de Janeiro,
calls for countries to pass legislation to "respect, preserve, and maintain knowledge, innovations,
and practices of indigenous and local communities" related to sustainable use of biological diversity.
Article 8(j) adds that countries should "encourage the equitable sharing of the benefits arising
from the utilization of such knowledge, innovations and practices." A draft UN Declaration on the
Rights of Indigenous People would give indigenous people "the right to the restitution of cultural,
intellectual, religious, and spiritual property taken without their free and informed consent or in
violation of their laws, traditions and customs." The same document would safeguard an indigenous
groups' right to protect their medicinal plants, animals, and minerals, and recognize their "full
ownership, control, and protection of their cultural and intellectual property." At the other end of
the spectrum is the 1994 Uruguay Round accord. This international agreement on free trade allows
member countries to protect plant varieties through patents or "an effective sui generis system," but
the issue has received little attention in countries with indigenous populations.

-- End --

©2011 The University of New Mexico,
Latin American & Iberian Institute
All rights reserved.

Page 3 of 3

